Clinical Trials Directory

Trials / Completed

CompletedNCT05799729

Effect of Ketamine Infusion on BIS Values

Correlation Between Concentration at the Effector Site of Continuous Infusion of Ketamine (Calculated With DOMINO Pump) and Bispectral Index Values During General Anaesthesia for Breast Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
University of Padova · Academic / Other
Sex
Female
Age
18 Years – 90 Years
Healthy volunteers

Summary

Aim of this trial is to define if Concentration at the effector site (Ce) of Ketamine, during a continuous infusion and calculated with DOMINO model infusion pump are correlated with Bispectral Index BIS values during general anaesthesia for breast surgery.

Detailed description

Correlation between Concentration at the effector site (Ce) of Ketamine and Bispectral Index (BIS) values during general anaesthesia for breast surgery has not been defined yet during a continuous infusion. Authors want to analyze this correlation during general anaesthesia conducted using Propofol, ketamine and remifentanil. All of these drugs will be delivered with Target-Controlled Infusion pumps (in particular Eleveld for Propofol, Minto for Remifentanil and Domino for Ketamine). Ketamine will be observationally set at anaesthesiologist's discretion, but only CeK 0.1, 0.2, 0.4 and 0.6 for at least 30 minutes will be considered for analysis.

Conditions

Interventions

TypeNameDescription
DRUGKetamineCeK will be set at anesthesiologist's discretion. Only patients with continuous infusion of CeK 0.1, 0.2, 0.4 or 0.6 for at least 30 minutes will be considered.

Timeline

Start date
2023-04-01
Primary completion
2023-09-30
Completion
2023-09-30
First posted
2023-04-05
Last updated
2023-10-19

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05799729. Inclusion in this directory is not an endorsement.